ArticleJournal of oncology practice2014
Oncologists' and primary care physicians' awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors.
Article in Journal of oncology practice, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Primary care physicians' knowledge and confidence in providing cancer survivorship care: a systematic review.Journal of cancer survivorship : research and practice · 2024Pooled it
- Management of Primary Ovarian Insufficiency Symptoms in Survivors of Childhood and Adolescent Cancer.Journal of the National Comprehensive Cancer Network : JNCCN · 2018Pooled it
- From consensus to implementation in cancer survivorship follow-up.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- Consensus document between oncology and primary care for the follow-up of cancer survivors.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- Myths and Presumptions About Cancer Survivorship.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024Article
- Review
- Baseline cardiac function checkup in patients with gastric or breast cancer receiving trastuzumab or anthracyclines.Cancer medicine · 2023Article
- Review
- Overcoming Obstacles in Transitions of Cancer Survivor Care.Journal of the National Cancer Institute · 2022Article
- Long-term assessment of efficacy with a novel Thoracic Survivorship Program for patients with lung cancer.The Journal of thoracic and cardiovascular surgery · 2022Article
- Developing personalized survivorship care pathways in the United States: Existing resources and remaining challenges.Cancer · 2021Article
- Healthcare provider perspectives on pediatric cancer survivorship care plans: a single institution pilot study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- Lifestyle among long-term survivors of cancers in young adulthood.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- Knowledge of iatrogenic premature ovarian insufficiency among Chinese obstetricians and gynaecologists: a national questionnaire survey.Journal of ovarian research · 2020Article
- Review
- Healthcare professionals' perspectives of barriers and facilitators in implementing physical activity programmes delivered to cancer survivors in a shared-care model: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020Article
- Definition and Coordination of Roles and Responsibilities Among Cancer Center Clinic and Research Personnel.JCO oncology practice · 2020Article
- Article
- Understanding Long-Term Cancer Survivors' Preferences for Ongoing Medical Care.Journal of general internal medicine · 2019Article
- NCCN Guidelines Insights: Survivorship, Version 2.2019.Journal of the National Comprehensive Cancer Network : JNCCN · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeThe population of cancer survivors is large and growing. Yet after successful completion of treatment, many experience chemotherapy-related late or long-term effects (LEs). The extent to which physicians are aware of LEs is unknown.
methodsWe conducted a nationally representative survey of 1,130 oncologists and 1,072 primary care providers (PCPs). Respondents were asked to select the LEs they had either observed or seen reported for five chemotherapy agents used to treat breast and colon cancers. We described and compared oncologists' and PCPs' awareness of the specified LEs. Using multivariate logistic regression models, we determined predictors of physicians' awareness of the main LEs associated with the agents.
resultsAlmost all oncologists (95%) reported awareness of cardiac dysfunction as an LE of doxorubicin and peripheral neuropathy as an LE of paclitaxel (97%) and oxaliplatin (97%). These LEs were reported by 55%, 27%, and 22% of PCPs, respectively. Most oncologists reported awareness of premature menopause (71%) and secondary malignancies (62%) as LEs of cyclophosphamide, compared with only 15% and 17% of PCPs, respectively. Main LEs associated with all four agents were identified by 65% of oncologists and only 6% of PCPs.
conclusionAlthough more than half of PCPs were aware of cardiac dysfunction as an LE of doxorubicin, awareness of other LEs was limited. Because PCPs may not be directly exposed to chemotherapy-related LEs, oncologists must communicate this information to PCPs as patients transition to primary care settings. Education for all providers caring for the growing population of cancer survivors is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.